Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPantheon Resources plc Regulatory News (PANR)

Share Price Information for Pantheon Resources plc (PANR)

Share Price is delayed by 15 minutes
Get Live Data
15.47    1.95 (14.42%)
Bid:
15.09
Ask:
15.47
Spread: 0.38 (2.518%)
Market Cap: £225.54m
PANR Live PriceLast checked at - London Stock Exchange

Intraday Pantheon Resources plc Share Chart

Drilling Update

22 Apr 2009 08:20

RNS Number : 9592Q
Pantheon Resources PLC
22 April 2009
 



Press release

22 April 2009

Jumonville #2 Bullseye Prospect 

Iberville Parish, Louisiana

Pantheon Resources ("Pantheon"), the AIM-quoted oil and gas exploration company active in the onshore region of the Gulf of Mexico, issues the following drilling update on the Jumonville #2 well on the Bullseye prospect. An initial petro-physical log analysis of the 12,400-14,100 feet log interval indicates that the Miogyp, upper Cib Haz, and lower Cib Haz sandstone units are all hydrocarbon-bearing. The combined net pay for all three intervals is calculated at 97 feet. This analysis was conducted by Schlumberger.

The Miogyp sandstone is about 20 feet thick. The log analysis indicates about 18 feet of hydrocarbon pay in this interval. This is in line with pre-drill estimates and confirms the extension of the currently producing field. This success should add to the current production and proven reserves base.

The deeper Cib Haz exploration target has two potential reservoir units. These consist of very thin-bedded to laminated sandstones, siltstones and shales. The upper Cib Haz zone is 130 feet thick and the lower sandstone zone about 60 feet thick. The log analysis indicates a total of 79 feet of net hydrocarbon pay in the combined upper and Lower Cib Haz sandstone intervals.

The log analysis does not indicate the type of hydrocarbon in the reservoir. However, as reported previously, data from the sidewall cores suggest that the lower Cib Haz interval is oil-bearing, while the upper may be gas-bearing. The Miogyp sandstone appears to be oil-bearing, judging from the mudlog shows and sidewall-core information. 

The Jumonville #2 well is on the same drill site as the Jumonville #1 well. Current surface facilities are available to put any new production from Jumonville #2 into the established sales lines.

While these results are very encouraging, they remain preliminary. Further analysis and production testing over the next several weeks should determine the commercial significance and reserve potential of the Cib Haz discoveries. Pantheon has an 11.25% working interest after back in rights. 

Jay Cheatham, CEO of Pantheon Resources, stated, "I am excited by the potential of this discovery. Pantheon is now waiting on a smaller rig to perform the completion and testing of the Jumonville #2 to confirm the quality of this new reservoir."

In accordance with the AIM Rules, the information in this report has been reviewed and signed off by Jay Cheatham, who has over 30 years' relevant experience within the sector. 

For further information on Pantheon Resources plc, see the website at www.pantheonresources.com

Enquiries:

Pantheon Resources plc

Jay Cheatham, CEO

+44 20 7484 5359

Oriel Securities Limited (Nominated Adviser)

Michael Shaw

+44 20 7710 7600

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DRLSEASWESUSEFL
Date   Source Headline
19th Dec 20237:00 amRNSFinal Results for the Year Ended 30 June 2023
14th Dec 20237:04 amRNSSuccessful Acquisition of Leases
12th Dec 20237:00 amRNSAppointment of Independent Non-Executive Director
21st Nov 20234:36 pmRNSStrategy Update
15th Nov 20231:54 pmRNSInvestor Presentation via Investor Meet Company
14th Nov 202311:56 amRNSBond Payment, Placement & Corporate Update
19th Oct 20237:00 amRNSValidation of frac design and fluid sampling
18th Oct 20237:00 amRNSPantheon Presenting at OTC Oil and Gas Conference
4th Oct 20237:00 amRNSReplacement TR-1: Notification of major holdings
3rd Oct 20234:02 pmRNSTR-1: Notification of major holdings
27th Sep 20237:00 amRNSCommencement of Operations - Re-entry of Alkaid-2
14th Sep 20233:34 pmRNSWebinar and update
8th Sep 20238:20 amRNSInvestor Presentation Webinar
7th Sep 20237:00 amRNSPrivate Placement
30th Aug 20237:00 amRNSDirector/PDMR Notification
29th Aug 20237:00 amRNSExpert Report Confirms Estimate for Kodiak Field
28th Jul 20237:57 amRNSReplacement Operational Update
28th Jul 20237:00 amRNSOperational Update
14th Jul 20239:30 amRNSInvestor Presentation via Investor Meet Company
10th Jul 20237:00 amRNSInvestor Presentation via Investor Meet Company
3rd Jul 20238:53 amRNSAppointment of Independent Non-Executive Director
28th Jun 20234:58 pmRNSWebinar and Strategy Update
26th Jun 202312:54 pmRNSUpcoming Webinar - Registration Details
15th Jun 20233:50 pmRNSIssue of Equity and Total Voting Rights
8th Jun 20237:00 amRNSAppointment of Executive Chairman
1st Jun 20237:00 amRNSLease Award
23rd May 20234:32 pmRNSUpdate on Fundraise
18th May 20235:40 pmRNSBlock Listing Six Monthly return
17th May 20237:00 amRNSResult of Capital Raise
16th May 20235:07 pmRNSRetail Offer via PrimaryBid
16th May 20234:59 pmRNSProposed Placing and Subscription
21st Apr 20237:00 amRNSOperational and corporate update
31st Mar 20237:00 amRNSUnaudited Interim Results
22nd Mar 20235:09 pmRNSResult of AGM
20th Mar 20234:45 pmRNSAGM update
20th Mar 20237:00 amRNSAGM webinar & corporate update
16th Mar 20232:08 pmRNSUpcoming Webinar – Registration Details
13th Mar 20233:33 pmRNSQuarterly Repayment of Unsecured Convertible Bonds
9th Mar 202312:17 pmRNSAppointment of Independent Non-Executive Director
6th Mar 20237:00 amRNSOperational and corporate update
21st Feb 20236:06 pmRNSAnnual General Meeting & Webinar
21st Feb 20237:00 amRNSOperational update, PDMR & Issue of Equity
16th Feb 20237:00 amRNSAlkaid #2 update – well cleanout completed
10th Feb 20237:00 amRNSAlkaid #2 update
24th Jan 20231:49 pmRNSAlkaid #2 webinar and update
23rd Jan 20237:00 amRNSUpcoming Webinar - Registration Details
13th Jan 202311:03 amRNSConfirmation of Upcoming Webinar
3rd Jan 20237:00 amRNSInvestor Q&A
30th Dec 20227:00 amRNSOperational update
30th Dec 20227:00 amRNSFinal Results for the Year Ended 30 June 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.